📣 VC round data is live. Check it out!

Nihon Kohden Valuation Multiples

Discover Nihon Kohden's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Poly Medicure, Nolato, Vitrolife, Staar Surgical and more.

Nihon Kohden Overview

About Nihon Kohden

Nihon Kohden Corp is a Japan-based company engaged in the development, manufacturing, and sale of medical electronic equipment. It offers monitoring and diagnostic equipment such as electroencephalographs, electrocardiographs, and patient monitors, along with related systems and consumables. The company operates as a single business segment and manages its activities comprehensively across three reportable regions: Japan, North America, and Other Regions.


Founded

1951

HQ

Japan

Employees

6.6K

Financials (LTM)

Revenue: $1B
EBITDA: $158M

EV

$1B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Nihon Kohden Financials

Nihon Kohden reported last 12-month revenue of $1B and EBITDA of $158M.

In the same LTM period, Nihon Kohden generated $769M in gross profit, $158M in EBITDA, and $92M in net income.

Revenue (LTM)


Nihon Kohden P&L

In the most recent fiscal year, Nihon Kohden reported revenue of $1B and EBITDA of $162M.

Nihon Kohden is profitable as of last fiscal year, with gross margin of 52%, EBITDA margin of 11%, and net margin of 6%.

See analyst estimates for Nihon Kohden
LTMLast FY202320242025202620272028
Revenue$1B$1B$1B$1B$1B
Gross Profit$769M$734M$689M$725M$759M
Gross Margin52%52%50%52%52%
EBITDA$158M$162M$201M$174M$155M
EBITDA Margin11%11%15%12%11%
EBIT Margin8%9%9%9%8%
Net Profit$92M$88M$107M$93M$91M
Net Margin6%6%8%7%6%

Financial data powered by Morningstar, Inc.

Nihon Kohden Stock Performance

Nihon Kohden has current market cap of $1B, and enterprise value of $1B.

Market Cap Evolution


Nihon Kohden's stock price is $8.79.

Nihon Kohden share price decreased by 3.3% in the last 30 days, and by 18.7% in the last year.

Nihon Kohden has an EPS (earnings per share) of $0.55.

See more trading valuation data for Nihon Kohden
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1B$1B-0.7%-3.3%-4.1%-18.7%$0.55

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Nihon Kohden Valuation Multiples

Nihon Kohden trades at 0.9x EV/Revenue multiple, and 8.1x EV/EBITDA.

See NTM and 2027E valuation multiples for Nihon Kohden

EV / Revenue (LTM)


Nihon Kohden Financial Valuation Multiples

As of June 4, 2026, Nihon Kohden has market cap of $1B and EV of $1B.

Nihon Kohden has a P/E ratio of 15.2x.

LTMLast FY202320242025202620272028
EV/Revenue0.9x0.9x0.9x0.9x0.9x
EV/EBITDA8.1x7.8x6.3x7.3x8.2x
EV/EBIT10.4x9.8x10.2x9.9x10.5x
EV/Gross Profit1.7x1.7x1.8x1.8x1.7x
P/E15.2x15.9x13.2x15.1x15.5x
EV/FCF14.7x30.8x37.4x26.6x18.0x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Nihon Kohden Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Nihon Kohden Margins & Growth Rates

Nihon Kohden grew revenue by 5% but EBITDA decreased by 6% in the last fiscal year.

In the most recent fiscal year, Nihon Kohden reported gross margin of 52%, EBITDA margin of 11%, and net margin of 6%.

See estimated margins and future growth rates for Nihon Kohden

Nihon Kohden Margins

Last FY202420252026202720282029
Gross Margin52%52%52%53%
EBITDA Margin11%12%11%12%
EBIT Margin9%9%8%9%
Net Margin6%7%6%7%
FCF Margin3%3%5%7%

Nihon Kohden Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth5%3%4%(1%)
Gross Profit Growth5%5%5%2%
EBITDA Growth(6%)(13%)(11%)12%
EBIT Growth(9%)2%(5%)12%
Net Profit Growth4%(13%)(2%)4%
FCF Growth95%41%48%49%

Data powered by FactSet, Inc. and Morningstar, Inc.

Nihon Kohden Operational KPIs

Nihon Kohden's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Nihon Kohden's Rule of 40 is 11% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Nihon Kohden's Rule of X is 9% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Nihon Kohden
LTMLast FY202320242025202620272028
Rule of 408%11%---
Bessemer Rule of X4%9%---
Revenue per Employee-$0.2M---
Opex per Employee-$0.1M---
R&D Expenses to Revenue3%---3%
Opex to Revenue-43%41%42%41%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Nihon Kohden Competitors

Nihon Kohden competitors include Poly Medicure, Nolato, Vitrolife, Staar Surgical, Anbio Biotechnology, SKAN Group, Haier Biomedical, Savaria, VCANBIO and El.En. Group.

Most Nihon Kohden public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Poly Medicure6.8x6.6x22.9x27.5x
Nolato1.4x1.4x8.5x8.5x
Vitrolife3.9x3.9x13.4x13.1x
Staar Surgical3.9x4.6x23.7x67.3x
Anbio Biotechnology162.7x-244.0x-
SKAN Group3.5x3.3x30.5x25.9x
Haier Biomedical3.6x3.5x21.3x21.2x
Savaria2.4x2.3x11.6x11.2x

This data is available for Pro users. Sign up to see all Nihon Kohden competitors and their valuation data.

Start Free Trial

Acquisitions by Nihon Kohden

Nihon Kohden has acquired 2 companies to date.

Last acquisition by Nihon Kohden was on September 12th 2024. Nihon Kohden acquired NeuroAdvanced for $15M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by Nihon Kohden

NeuroAdvanced
AMP3D
Description
NeuroAdvanced is the parent corporation of Ad-Tech Medical Instrument Corporation, a provider of precision EEG electrodes and neuroimaging accessories. Based in Nottingham, Pennsylvania, the company supplies invasive and non-invasive monitoring devices to epilepsy centers and research labs globally. Its products feature in clinical trials for over 200 hospitals in the United States.
AMP3D is a Pittsburgh-based developer of healthcare analytics platforms for predictive displays and diagnostics. Its Big Data tools forecast events like intubation, hemorrhage, and sepsis in ICUs to enable early interventions across US hospitals.
HQ CountryUnited StatesUnited States
HQ City
Philadelphia, PA
Charlottesville, VA
Deal Date12 Sep 20249 Aug 2021
Valuation$15Mundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Nihon Kohden acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Nihon Kohden

When was Nihon Kohden founded?Nihon Kohden was founded in 1951.
Where is Nihon Kohden headquartered?Nihon Kohden is headquartered in Japan.
How many employees does Nihon Kohden have?As of today, Nihon Kohden has over 6K employees.
Who is the CEO of Nihon Kohden?Nihon Kohden's CEO is Hirokazu Ogino.
Is Nihon Kohden publicly listed?Yes, Nihon Kohden is a public company listed on Tokyo Stock Exchange.
What is the stock symbol of Nihon Kohden?Nihon Kohden trades under 6849 ticker.
When did Nihon Kohden go public?Nihon Kohden went public in 1961.
Who are competitors of Nihon Kohden?Nihon Kohden main competitors include Poly Medicure, Nolato, Vitrolife, Staar Surgical, Anbio Biotechnology, SKAN Group, Haier Biomedical, Savaria, VCANBIO, El.En. Group.
What is the current market cap of Nihon Kohden?Nihon Kohden's current market cap is $1B.
What is the current revenue of Nihon Kohden?Nihon Kohden's last 12 months revenue is $1B.
What is the current revenue growth of Nihon Kohden?Nihon Kohden revenue growth (NTM/LTM) is (3%).
What is the current EV/Revenue multiple of Nihon Kohden?Current revenue multiple of Nihon Kohden is 0.9x.
What is the current EBITDA of Nihon Kohden?Nihon Kohden's last 12 months EBITDA is $158M.
What is Nihon Kohden's EBITDA margin?Nihon Kohden's last 12 months EBITDA margin is 11%.
What is the current EV/EBITDA multiple of Nihon Kohden?Current EBITDA multiple of Nihon Kohden is 8.1x.
What is the current FCF of Nihon Kohden?Nihon Kohden's last 12 months FCF is $86M.
What is Nihon Kohden's FCF margin?Nihon Kohden's last 12 months FCF margin is 6%.
What is the current EV/FCF multiple of Nihon Kohden?Current FCF multiple of Nihon Kohden is 14.7x.
How many companies Nihon Kohden has acquired to date?As of June 2026, Nihon Kohden has acquired 2 companies.
What was the largest acquisition by Nihon Kohden?$15M acquisition of NeuroAdvanced on 12th September 2024 was the largest M&A Nihon Kohden has done to date.
What companies Nihon Kohden acquired?Nihon Kohden acquired NeuroAdvanced and AMP3D.
In how many companies Nihon Kohden has invested to date?Nihon Kohden hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Nihon Kohden

Lists including Nihon Kohden

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial